Company ProfilePremium

AksharChem (India) Limited

Company Profile Analysis

Tickers: AKSHARCHEM.NS, 524598.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
AksharChem (India) Limited - Company showcase

Year Founded & Workforce

1989

165 Employees

AksharChem (India) Limited logo

AksharChem (India) Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

AksharChem (India) Limited Overview

AksharChem (India) Limited is a Gujarat-based, promoter-controlled manufacturer of colour chemicals and inorganic specialty fillers. Its legacy franchise is Vinyl Sulphone (VS) — a key intermediate for reactive dyes — where the company describes itself as one of India's leading exporters, supplemented by H-Acid, reactive dyes, and copper phthalocyanine (CPC) Green pigment (Pigment Green 7, brand "Asaflow") inherited from sister company Asahi Songwon Colors in 2014. Since 2022 it has diversified into precipitated silica (brand "Aksil") at Dahej for tyre, rubber, agrochemical and animal-feed customers, scaling capacity to 18,000 TPA in June 2025. The company exports to more than 30 countries but has re-emphasised the domestic market. After three weak years (FY2023–FY2026) marked by Chinese price competition, a May-2024 fire at its VS plant, rising debt and thin margins, Q1 FY2027 delivered a sharp earnings inflection (PAT ₹15.2 Cr on ~₹141 Cr revenue), which has re-rated the stock roughly 2.5x from its March-2026 lows.


Company's own description (FY2024-25 Annual Report, MD&A)

In its most recent available Management Discussion & Analysis (36th Annual Report, FY2024-25), the company characterises itself as one of India's leading chemical manufacturers with an export focus spanning over 30 countries, while noting it has redirected attention to the domestic market as a future growth driver. It divides its offering into organic chemicals (Vinyl Sulphone, H-Acid, CPC Green) serving textile, ink, plastic and paint applications, and inorganic chemicals (precipitated silica) serving tyre, rubber, agrochemical and animal-feed industries. Manufacturing is located at Chhatral/Indrad (Mehsana) and Dahej. The MD&A states that FY2024-25 production volume was 19,224 MT with blended capacity utilisation of 82%, and that the company has "successfully penetrated" the precipitated silica requirements of major Indian tyre and rubber makers, with expansion options under evaluation across conventional precipitated silica, micro-pearl silica and highly dispersible silica (HDS). Brand names cited: Asaflow (Pigment Green 7) and Aksil (precipitated silica).

Independent characterisation

AksharChem is best understood as a two-engine, B2B commodity-to-specialty chemical producer:

  1. Colour chemicals engine (Indrad, Mehsana): A mid-sized, non-integrated producer of naphthalene/benzene-derived dye intermediates (VS, H-Acid), a small reactive-dye line (Reactive Blue 21, Reactive Black 5 per third-party descriptions), and a CPC Green pigment line. Economics are dictated by the spread between intermediate prices and raw materials (acetanilide, chlorosulphonic acid, naphthalene derivatives, copper phthalocyanine crude), and above all by Chinese supply discipline and Chinese environmental enforcement. This is a classic cyclical "China-plus-one" business: margins expand when Chinese capacity is shut or constrained and collapse when Chinese exports flood the market.

  2. Inorganic fillers engine (Dahej): Precipitated silica, a reinforcing filler used predominantly in tyres (especially "green tyre" formulations where HDS grades reduce rolling resistance), footwear and technical rubber, and as a carrier/anti-caking agent in agrochemicals and animal feed. This business is more domestically anchored, tied to Indian tyre-capacity expansion and import substitution, and structurally less exposed to Chinese dye-intermediate cycles — although it competes with imports and with multinational producers.

Business model and revenue model. Revenue is almost entirely product sales (manufacturing for spot and contract supply), with no meaningful service, subscription or licensing income. The company sells to dye manufacturers (VS, H-Acid), textile processors/traders (reactive dyes), paint, ink and plastics compounders (Pigment Green 7), and tyre/rubber/agro/feed processors (silica). Ancillary operating income includes export incentives and scrap; FY2026 also included insurance-claim receipts booked as exceptional items.

Value-chain position. Mid-stream. AksharChem buys basic and intermediate chemicals (it is not backward-integrated into sulphuric acid, chlor-alkali or benzene derivatives, unlike Bodal Chemicals) and sells intermediates and colorants into further-downstream formulators. In silica it converts sodium silicate and sulphuric acid into finished filler grades.

Customer types. Industrial manufacturers and global chemical majors (the company states it supplies VS to "the world's leading chemical companies"); Indian tyre majors in silica. Customer concentration is not publicly disclosed in sources reviewed.

End-markets. Textiles (cotton reactive dyeing), paints & coatings, printing inks, plastics masterbatch, tyres and technical rubber, agrochemicals, animal feed.

Strategy

Stated strategic themes (FY2024-25 MD&A and company website)

The company has not held an investor day, and no formal medium-term strategy document was identified. Its stated themes, paraphrased, are:

  1. Domestic market as a growth driver alongside a 30+ country export base.

  2. Precipitated silica scale-up, including evaluation of conventional, micro-pearl and highly dispersible grades for the tyre industry.

  3. Operational excellence: website "Key Highlights" cite ~80% capacity utilisation through better planning and plant uptime, packaging automation, long-term raw-material supply contracts, shop-floor training and acquisition of new overseas customers.

  4. Environmental positioning: the company describes itself as among the most environment-friendly chemical companies; pollution-treatment expenditure is tracked as a KPI (Screener lists "Annual Pollution Treatment Expenses as % of Revenue").

Strategic initiatives announced in the last 24 months

InitiativeDateDescriptionStatus
Dahej precipitated silica expansionCommissioned 24-Jun-2025+6,000 TPA to 18,000 TPA; aimed at tyre and rubber customers; broader size range and product selectionCompleted
VS plant reconstruction after fireMay–Dec 2024Rebuild of dry zone; regulatory trial revocation from GPCBCompleted; insurance partly settled
Captive solar — BanaskanthaOperating 12-Nov-20255.19 MWp DC ground-mounted, reduces grid power cost at IndradCompleted
Captive solar — BharuchOperating 24-Apr-20262.4 MWp DC for Dahej silica plantCompleted
Executive bench refresh21-May-2026WTD appointmentCompleted
HDS / micro-pearl silicaUnder evaluation (FY25 MD&A)Higher-value tyre-tread silicaNo capex announcement verified

Guidance and targets

Management guidance: Not publicly disclosed. No revenue, margin or capex guidance was found in filings, and no earnings-call transcripts exist. Cost programmes with targets: None quantified publicly. Sustainability targets: No quantified emissions or renewable-share targets disclosed; the ~7.6 MWp of captive solar is the tangible commitment.

Products & Services

Pricing is market-determined and not disclosed by the company. Launch years are given where verifiable.

Dye Intermediates Division (Indrad)

ProductDescription & key specsTarget customerLaunch / statusNotes
Vinyl Sulphone Ester (VS, "Acetanilide base"), para-base4-β-sulphatoethylsulphonyl aniline; the reactive anchor in vinyl-sulphone reactive dyes (e.g., Reactive Black 5)Reactive dye manufacturers in India, China, Europe, SE AsiaCore product since founding (1989/1990s)Company claims to be one of India's leading VS exporters and among the fastest-growing VS makers
Ortho Anisidine Vinyl Sulphone (OAVS)VS derivative based on o-anisidine; used for specific reactive dye shadesReactive dye makersListed in portfolioPer Wright Research product description
Sulpho Para Vinyl Sulphone (Sulpho VS)Sulphonated VS variant for bi-functional reactive dyesReactive dye makersListed in portfolioPer Wright Research
H-Acid1-amino-8-naphthol-3,6-disulphonic acid; key coupling component for azo reactive and direct dyesDye manufacturersAdded in FY2017-18 capex cycle1,200 MTPA; utilisation 96% (Tijori). Prices firmed through Q3-2025–Q1-2026 per industry trackers

Dyes Division (Indrad)

ProductDescriptionTarget customerStatus
Reactive Blue 21Copper-phthalocyanine-based turquoise reactive dyeCotton textile dyers/printersListed in portfolio
Reactive Black 5Bis-vinyl-sulphone reactive black; the single largest-volume reactive dye globallyCotton textile dyersListed in portfolio

Pigments Division (Indrad; brand "Asaflow")

ProductDescriptionTarget customerStatus
Pigment Green 7 (CPC Green, C.I. 74260)Chlorinated copper phthalocyanine green; high light/heat/chemical fastnessPaints, printing inks, plastics masterbatchTransferred from Asahi Songwon via demerger effective 1-Apr-2014; 2,400 MTPA
Pigment Violet 23Carbazole dioxazine violetInks, coatings, plasticsListed in third-party portfolio descriptions

Inorganic Division (Dahej; brand "Aksil")

Product familyDescriptionTarget customerStatus
Conventional precipitated silicaAmorphous synthetic silica (SiO₂) produced by acidification of sodium silicate; reinforcing fillerTyres (non-tread compounds), footwear, technical rubberCommercial since 2022
Precipitated silica for agro/feedCarrier, flow and anti-caking agentAgrochemical formulators; animal-feed premix makersCommercial
Micro-pearl silica (MP)Granulated, low-dust grade for better dispersionTyre and rubber compoundersUnder consideration per FY25 MD&A
Highly Dispersible Silica (HDS)Premium grade for "green tyre" treads (lower rolling resistance, better wet grip)Tyre OEMsUnder consideration per FY25 MD&A; not yet confirmed commercial

Captive energy assets (non-revenue)

AssetCapacityLocationCommissioned
Ground-mounted solar5.19 MWp DC / 3.85 MW ACMakdala, Deodar, Banaskantha12-Nov-2025
Ground-mounted solar2.4 MWp DC / 1.75 MW ACSardarpura, Jhagadiya, Bharuch (supplies Dahej)24-Apr-2026

Financial Narrative

Basis: Standalone, Ind AS, INR M, fiscal years ending 31 March. Primary dataset: S&P Global Market Intelligence (via StockAnalysis.com, updated 12-Aug-2026), cross-checked against exchange filings (FY2024 and FY2026 newspaper extracts; FY2026 iXBRL). EBITDA is derived from the S&P EV/EBITDA ratio and matches Screener's "operating profit" within rounding. Margins and coverage ratios are analyst calculations.

Income statement: notes and sources

Notes: FY2022 EPS is ₹19.50 per TipRanks and ₹19.81 per Screener (weighted-share-count difference around the Dec-2021 buyback). FY2026 exceptional item of ₹169.61 lakh (₹17.0 M) is the fire-insurance receipt recognised in Q3 FY26; FY2026 PBT before exceptional items was ₹-61.4 M (₹-613.92 lakh per the company's newspaper extract). DPS for FY2022–FY2024 is derived from dividends paid in the following year's cash-flow statement (₹3.9–4.0 M on 8.03 M shares ≈ ₹0.50); FY2025 dividend of ₹60.25 lakh total (₹0.75/share) per the FY25 Directors' Report; FY2026 ₹0.50 (5%) per the 21-May-2026 outcome.

Margin profile (%)

Revenue CAGR: FY2021–FY2026 (5-year, FY2021 revenue ₹2,460 M per TipRanks): +8.6% (Screener independently reports 8.61% five-year sales growth). FY2022–FY2026 (4-year): -0.5%. FY2024–FY2026 (2-year): +11.0%.

Commentary — income statement. The five-year arc is a textbook commodity cycle compounded by company-specific shocks. FY2022 was a peak: post-COVID textile restocking and Chinese supply constraints pushed revenue up 54% and EBITDA to ₹316 M. FY2023 and FY2024 saw a double compression — revenue fell 21% cumulatively as Chinese VS and H-Acid exports normalised and realisations slumped, while EBITDA collapsed to just ₹14 M in FY2024 (0.5% margin), producing a ₹187 M net loss inflated by a ₹31 M tax charge despite a pre-tax loss (likely deferred-tax write-downs). FY2025 recovered (+14.6% revenue, EBITDA ₹247 M) even though the VS plant was shut for over seven months after the 2-May-2024 fire — indicating the silica business and H-Acid were carrying the company. FY2026 revenue grew 7.6% to a record ₹3,724 M, but EBITDA fell to ₹169 M as depreciation (Dahej expansion, solar assets) and interest (debt up 63%) rose, quarterly volatility was high (Q3 FY26 loss of ₹46 M), and the year closed with a ₹4.4 M net loss only after a ₹40 M tax credit and ₹17 M of insurance income. The headline FY2026 Q4 PAT of ₹48.4 M on a pre-tax loss of ₹10.0 M underscores that reported earnings were tax-driven, not operating-driven.

Q1 FY2027 inflection. The June-2026 quarter is the first unambiguous operating turnaround: revenue ~₹1,409 M (+45.3% YoY), PBT ₹159.5 M (vs ₹10.3 M), PAT ₹152.1 M, EPS ₹18.94, with no exceptional items (ScanX; Bajaj Broking). Net margin was ~10.8%. Single-quarter PAT exceeded the cumulative PAT of FY2023–FY2026 combined. Investor commentary attributes this to an H-Acid/VS price upcycle linked to Chinese supply developments and ~25% YoY firmer silica pricing (ValuePickr forum post).

Quarterly trajectory: notes and sources

Sources: Q1FY26 total income ₹969.99 M (multibagg/TipRanks ₹969.62 M); Q2FY26 sales ₹893.0 M (Geojit/Capitaline); Q3FY26 net loss ₹461.56 lakh (NSE iXBRL), revenue derived from net-margin data (Bajaj Broking, -5.74%) — approximate; Q4FY26 revenue ₹1,057.9 M and PAT ₹48.35 M (company extract; Groww); Q1FY27 per ScanX/Bajaj Broking. Interest per Arthneeti quarterly data (₹ Cr ×10). Q2/Q3 FY26 EPS are analyst calculations on 8.03 M shares.

Balance sheet

Source: S&P via StockAnalysis (balance sheet updated 12-Aug-2026). Cash discrepancy: one StockAnalysis view shows FY2026 cash of ₹17.42 M, while the detailed view shows ₹1.53 M for 31-Mar-2026 and ₹17.42 M for 30-Jun-2026; the latter attribution is used. Screener shows borrowings of ₹108 Cr (FY26), ₹67 Cr (FY25), ₹52 Cr (FY24), consistent with the table.

Commentary — balance sheet. The balance sheet has shifted from conservatively financed to moderately stretched. Net debt more than quadrupled from ₹245 M (FY2023) to ₹1,083 M (FY2026), funded primarily through short-term working-capital borrowings (₹805 M of the ₹1,085 M total), while long-term debt stayed modest. The driver was a ₹970 M cumulative capex programme over FY2024–FY2026 (Dahej silica expansion, solar plants, VS plant reconstruction) that was not covered by operating cash flow. Working capital turned negative (₹-22 M) and the current ratio fell below 1.0x (0.99x) at FY2026 — a liquidity watch-point given the company holds virtually no cash. Equity has been flat at ~₹2.6 bn for three years (book value ~₹326/share), so leverage remains moderate in absolute terms (net debt/equity 0.41x), but the maturity profile is short. There is no goodwill; intangibles are immaterial. Asset backing is tangible (land ₹271 M, buildings ₹866 M, plant & machinery ₹2,947 M gross per S&P), which supports lender comfort.

Cash flow

Buyback FY2022 = 1,69,491 shares × ₹590 = ₹100.0 M (tender offer, letter of offer dated 30-Nov-2021); S&P groups it within "other financing activities" (₹-143.5 M including buyback tax and lease/interest items).

Commentary — cash flow. AksharChem has generated positive free cash flow in only one of the last five years (FY2023, when a ₹239 M working-capital release coincided with low capex). Cumulative FCF over FY2022–FY2026 is approximately ₹-587 M, matched by ~₹937 M of net new borrowing — i.e., the company has borrowed to fund both capex and working capital. OCF is highly volatile because receivables and inventories swing with commodity prices: FY2026 OCF of only ₹17 M reflects a ₹148 M increase in receivables (DSO rose to ~61 days) as Q4 revenue spiked. Dividend outflows are token (₹4–6 M). The FY2023 outlier shows that, in a downturn, working-capital release can temporarily mask poor earnings.

Return, leverage and efficiency ratios

Sources: ROE/ROA/ROIC/ROCE, current/quick ratios, D/E, net debt/EBITDA, asset and inventory turnover per S&P via StockAnalysis; coverage ratios and working-capital days are analyst calculations from the tables above (days computed on revenue for consistency, because the FY2026 COGS reclassification distorts COGS-based measures). Tijori Finance reports a cash conversion cycle of 24.7 days (inventory 56.8, receivable 46.4, payable 81.5 days, COGS-based, period not specified) — a materially different methodology; both are noted.

Commentary — ratios. Returns on capital have been sub-economic for four straight years: ROIC peaked at 5.6% (FY2022) and averaged roughly -0.2% over FY2023–FY2026, far below any reasonable cost of capital for a cyclical Indian micro-cap (12–14%). The pattern reflects a capital base (₹2.6 bn equity plus ₹1.1 bn debt) that has grown with capex while EBITDA has not. The trailing picture changes dramatically if Q1 FY2027 is sustained: annualising Q1 PAT of ₹152 M would imply ROE above 20%. S&P's "current" ROIC of 4.42% (TTM to Jun-2026) already shows the improvement. Interest coverage is the key financial risk metric — at 0.1x EBIT/interest in FY2026 the company was dependent on lender forbearance in a downturn; Q1 FY2027 coverage is comfortably above 5x.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Margins & Growth (%)

SegmentFY2024FY2025FY2026

Chemicals (single reportable segment) revenue INR Mn

3,0203,4633,724

YoY growth %

-9.814.67.6

% of total revenue

100100100

Product Lines

Product lineInstalled capacity (MTPA)LocationLatest disclosed utilisationSource

Vinyl Sulphone (VS, incl. OAVS/Sulpho VS variants)

7,800

Indrad, Mehsana

79%

Tijori Finance

H-Acid

1,200

Indrad, Mehsana

96%

Tijori Finance

Dye intermediates combined

9,000

Indrad

—

Tijori Finance

CPC Green (Pigment Green 7; Violet 23 listed)

2,400

Indrad

78%

Tijori Finance

Precipitated silica (Aksil)

12,000 → 18,000 (from 24-Jun-2025)

Dahej

not disclosed post-expansion

Equitybulls; Tijori

Total (pre-expansion)

23,400

—

82% blended (FY2025)

IIFL; FY25 MD&A

Total (post-expansion, analyst calc.)

29,400

——

Analyst calculation

“—” = not publicly disclosed.

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue INR Mn

3,8033,3473,0203,4633,724

Revenue growth %

54.3-12.0-9.814.67.6

Gross profit INR Mn (S&P basis)

1,4711,1381,1821,454969

EBITDA INR Mn

31615314247169

Depreciation & amortisation INR Mn

121128137139164

Operating income (EBIT) INR Mn

19526-1231085

Interest expense INR Mn

1627334668

Exceptional / unusual items INR Mn

500-4017

Pre-tax income INR Mn

179-5-15658-44

Income tax expense INR Mn

2043111-40

Net income INR Mn

159-9-18748-4

EPS basic INR

19.50-1.17-23.255.94-0.55

EPS diluted INR

19.50-1.17-23.255.94-0.55

Dividend per share INR

0.500.500.500.750.50

Margin Analysis (%) — Gross margin %

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin % (S&P basis; FY26 not comparable)

38.734.039.142.026.0

EBITDA margin %

8.34.60.57.14.5

Operating (EBIT) margin %

5.10.8-4.13.10.1

Pre-tax margin %

4.7-0.1-5.21.7-1.2

Net margin %

4.2-0.3-6.21.4-0.1

Financial Analysis

MetricQ1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Revenue INR Mn

9708938051,0581,409

Net profit INR Mn

7.1-13.7-46.248.4152.1

EPS INR

0.89-1.70-5.756.0218.94

Interest INR Mn

14.313.818.521.5—

“—” = not publicly disclosed.

Financial Analysis (Annual)

MetricFY2022FY2023FY2024FY2025FY2026

Total assets INR Mn

4,0603,6523,8054,1534,516

Cash & equivalents INR Mn

1.41.51.61.41.5

Short-term debt incl. current LTD INR Mn

27881344535906

Long-term debt INR Mn

225165175133179

Total debt INR Mn

5032465186681,085

Net debt INR Mn

5012455176661,083

Shareholders' equity INR Mn

2,7972,7842,5922,6372,615

Goodwill & intangibles INR Mn

4.03.02.21.50.9

Net PP&E INR Mn

2,4682,4262,4572,7602,954

Capital work-in-progress INR Mn

16017411244684

Receivables INR Mn

549374484462646

Inventory INR Mn

725593649705730

Trade payables INR Mn

501383435574539

Working capital INR Mn

669649483190-22

Book value per share INR

348.2346.5322.7328.3325.6

Financial Analysis (FY2022–FY2026)

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow INR Mn

43379-6634817

Change in working capital INR Mn

-232239-129101-169

Capital expenditure INR Mn

24989168442360

Free cash flow INR Mn

-206290-234-94-343

Dividends paid INR Mn

29.53.94.04.06.0

Share buybacks INR Mn

1000000

Net debt issued (repaid) INR Mn

355-256272149417

Cash interest paid INR Mn

20.633.637.352.668.2

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE %

5.70-0.34-6.951.82-0.17

ROA %

3.200.42-2.061.700.07

ROIC %

5.560.81-4.002.770.14

ROCE %

6.100.80-4.103.600.20

Current ratio x

1.782.251.591.170.99

Quick ratio x

0.640.720.590.400.42

Debt to equity x

0.180.090.200.250.42

Net debt to EBITDA x

1.591.6036.412.696.40

Interest coverage EBIT to interest x

11.90.9-3.72.40.1

EBITDA to interest x

19.45.60.45.42.5

Asset turnover x

1.000.870.810.870.86

Inventory turnover x

3.583.352.962.973.18

Receivable days (revenue basis)

5139574361

Inventory days (revenue basis)

7065787472

Payable days (revenue basis)

4842536153

Cash conversion cycle days (revenue basis)

7262835780

Valuation Snapshot

MetricValueAs ofSource

Last close

₹419.90 (BSE) / ₹418

16/17-Oct-2026

StockAnalysis; Kotak Neo

1-month return

+8.2%

16-Oct-2026

MarketsMojo

6-month return

+113.0%

16-Oct-2026

MarketsMojo

1-year return

+55.1%

16-Oct-2026

MarketsMojo

3-year return

~+32.6%

13-Sep-2026

Anand Rathi

52-week high / low

₹472 / ₹141.30

16-Oct-2026

Kotak Neo

Fiscal year-end closing prices

FY22 ₹345.26; FY23 ₹203.60; FY24 ₹250.63; FY25 ₹213.06; FY26 ₹144.73

—

S&P via StockAnalysis

Capital Markets

MetricFY2022FY2023FY2024FY2025FY2026

Closing share price INR

345.26203.60250.63213.06144.73

Market capitalisation INR Mn

2,7971,6472,0241,7181,164

Enterprise value INR Mn

2,9321,9112,3752,3681,891

Valuation Multiples

MultipleAksharChem (current, 15-Oct-2026)AksharChem FY2026 year-endPeer reference (Fyers peer table, ~Oct-2026)

P/E (TTM)

23.8x

n.m. (loss)

Bodal 35.8x; Bhageria 22.7x; Shree Pushkar 22.1x; Ultramarine 13.6x; Asahi Songwon 13.2x; Sudarshan 133.9x

EV/EBITDA

13.3x11.2x

Bodal 11.0x; Kiri 4.4x; Vidhi 12.5x

EV/Sales

1.07x0.51x—

P/B

1.29x0.45x—

Dividend yield

0.12%0.34%—

Capital Markets — Dividend per share INR

MetricFY2022FY2023FY2024FY2025FY2026

Dividend per share INR

0.500.500.500.750.50

Dividend as % of face value

5.05.05.07.55.0

Analyst Conclusions

Management guidance

None publicly issued. The company does not provide quantitative guidance or hold earnings calls.

Consensus growth expectations

None available (no published estimates).

Bull case (grounded in data)

  1. Cycle has turned decisively. Q1 FY27 revenue grew 45% YoY and PAT reached ₹152 M with no exceptional items — evidence that H-Acid/VS spreads and silica pricing have moved structurally higher with Chinese supply constraints. If even half of Q1's profitability persists, FY2027 EPS could exceed ₹40, putting the stock at ~10x forward earnings.

  2. Capex cycle complete, cash harvest ahead. FY2024–FY2026 capex of ~₹970 M (silica expansion, plant rebuild, solar) is now in the asset base; with capex normalising toward maintenance levels and EBITDA rising, FCF could turn strongly positive, deleveraging the ₹1,083 M net debt within roughly two years.

  3. Asset value floor. Book value of ~₹326/share and a tangible, recently-expanded plant base mean the stock trades at only ~1.3x book despite a potential return to double-digit ROE; replacement cost of an 18,000 TPA silica plant plus 9,000 MTPA of intermediates capacity likely exceeds the current ~₹444 Cr EV.

Bear case (grounded in data)

  1. Cyclical peak, not new normal. In FY2022 the company also posted strong earnings, followed by two years in which revenue fell 21% and EBITDA collapsed to ₹14 M. Chinese supply disruptions historically reverse within quarters; the stock's 190% rise from the March-2026 low may be capitalising peak earnings.

  2. Weak balance-sheet resilience. With near-zero cash, a 0.99x current ratio, ~84% of debt short-dated and FY2026 EBIT/interest of 0.1x, a renewed downturn would quickly pressure liquidity and could force equity dilution or asset sales.

  3. Structural disadvantages persist. Sub-scale, non-integrated, near-zero R&D, single-site concentration, and environmental-regulatory exposure (the 2024 GPCB episode) cap through-cycle returns — ROIC has averaged below 1% over four years, and governance is concentrated in the founding family.

Key catalysts and monitorables (next 12 months)

CatalystTimingWhat to watch
Q2 FY27 results19-Oct-2026Sustainability of Q1 margins (EBITDA margin ≥12%?), working-capital build, debt level
Q3 FY27 results~Jan/Feb-2027Seasonal textile demand; Chinese supply normalisation
FY27 results & dividend~May-2027Full-year ROE, dividend uplift, debt reduction
Chinese H-Acid/VS supplyContinuousRestart of Chinese capacity, feedstock (naphthalene/coal tar) availability, Chinese environmental inspections
Silica pricing and HDS decisionContinuousAny capex announcement for micro-pearl/HDS silica; tyre OEM approvals
Exchange surveillance statusContinuousExit from BE/trade-to-trade series and ASM would improve liquidity
Insurance claim final settlementUnspecifiedAdditional exceptional income
RegulatoryContinuousGPCB consent renewals; any environmental notices in the Mehsana cluster

Concluding analyst verdict

AksharChem is a small, promoter-controlled Gujarat chemical manufacturer whose investment case has abruptly shifted from "deep value with no catalyst" to "cyclical earnings inflection priced for continuation." For four years the company destroyed value on any return-on-capital measure: revenue was roughly flat from FY2022 to FY2026 at about ₹370–380 Cr, EBITDA margins oscillated between 0.5% and 8%, free cash flow was negative in four of five years, and net debt quadrupled to ₹108 Cr as management completed a silica expansion, rebuilt a fire-damaged VS plant and installed captive solar. The stock reflected this, bottoming near 0.45x book in March 2026.

The June-2026 quarter changed the narrative. PAT of ₹15.2 Cr — more than the previous four fiscal years combined — on 45% revenue growth, with no exceptional items, shows how much operating leverage sits in a fully built, well-utilised asset base when dye-intermediate spreads widen. The market has responded, re-rating the shares to ~₹420 (≈1.3x book, ≈24x trailing earnings, ≈13x trailing EV/EBITDA).

Our assessment is that the improvement is real but its durability is unproven. The earnings driver — tighter Chinese H-Acid/VS supply and firmer silica prices — is exogenous and historically mean-reverting, while the company's structural handicaps (scale, lack of integration, negligible R&D, short-dated debt, concentrated governance, single-site risk) are unchanged. The silica business is the genuine long-term differentiator and deserves monitoring for any move into higher-value HDS grades.

On balance, AksharChem merits a neutral, catalyst-dependent stance: the Q2 FY27 print on 19-Oct-2026 is pivotal. Two consecutive quarters of double-digit EBITDA margins with visible debt reduction would justify further upside toward a sustained mid-teens ROE valuation; a reversion toward FY2026-type margins would leave the current price exposed to a sharp de-rating, amplified by low float and trade-to-trade trading.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure / datesBackgroundTotal compensation (INR Mn, latest available)Source

Mrs. Paru M. Jaykrishna

Founder, Chairperson & Managing Director

Since 1989 (~36 years); reappointed for 1-Apr-2026 to 31-Mar-2029

Law graduate; bachelor's degrees in Philosophy and Sanskrit, master's in English Literature; first woman elected President of the Gujarat Chamber of Commerce & Industry; former director, Tourism Corporation of Gujarat; also founder-CMD of Asahi Songwon Colors Ltd

6.00

Simply Wall St; Asahi Songwon corporate info; ScanX

Mr. Munjal M. Jaykrishna

Joint Managing Director & CEO

Joint MD since 2009; CEO since 14-Feb-2018 (previously CFO); age ~55

Promoter family; reappointed at 36th/37th AGM cycle

9.13

Simply Wall St; 2009 Annual Report

Mr. Devalkumar Indrabal Suthar (DIN 11511925)

Whole-Time Director (Executive)

21-May-2026 to 20-May-2029; shareholder approval sought by postal ballot (e-voting closed 30-Jun-2026)

Background not publicly detailed in sources reviewed

—

ScanX

Mr. Ashok Barot

Executive Director

~6 years; resignation noted by board 21-May-2026

—1.73

Simply Wall St; ScanX

Mr. Amit Soni

Chief Financial Officer

Appointed within the last ~1–2 years

—2.98

Simply Wall St

Mr. Mehul Naliyadhara

Company Secretary & Compliance Officer

~1.3+ years (signatory to filings since 2024)

—

0.15 (partial year)

Simply Wall St; NSE filings

Mr. Maheshkumar Patel

Vice President, Operations & Projects

——3.26

Simply Wall St

Mr. Dakshesh Patel

General Manager, Marketing

———

Simply Wall St

Mr. Rajesh Samal

General Manager (Works)

Resigned effective 31-Oct-2025

——

ScanX

“—” = not publicly disclosed.

Board & Management Changes

DateChangeContext

25-Jul-2025

Board approves reappointment of Paru M. Jaykrishna as CMD for FY2027–FY2029

Continuity of founder control

31-Oct-2025

GM (Works) Rajesh Samal resigns

Plant-level leadership change shortly after VS plant restart

21-May-2026

Executive Director Ashok Barot resigns; Devalkumar Suthar appointed WTD

Refresh of executive board bench

22-Sep-2026

37th AGM approves reappointment of Jaykrishna family directors retiring by rotation

—

Major Shareholders

Holder categoryStake %Source

Promoter & promoter group (Jaykrishna family and entities)

62.70

IndMoney; Anand Rathi

Foreign institutional investors

0.00

Anand Rathi

Domestic institutional investors

0.06

Anand Rathi

Retail and other public

~37.24

IndMoney; Kotak Neo

Competitive Landscape

Competitors by Segment

Product lineNamed competitorsNotes

Vinyl Sulphone

Bodal Chemicals (6,000 MTPA new VS plant commissioned 2023 at SPS), Kiri Industries, Shree Pushkar Chemicals & Fertilisers, Bhageria Industries, multiple Chinese producers (Zhejiang/Jiangsu cluster), unlisted Gujarat producers

VS is fragmented; China sets price

H-Acid

Bodal Chemicals, Kiri Industries, Atul Ltd, Chinese producers

Prices highly sensitive to Chinese naphthalene-chain disruptions

Reactive dyes

Bodal Chemicals, Kiri Industries, Atul Ltd, Colourtex (unlisted), Archroma/Huntsman-type MNCs, Chinese majors (Zhejiang Longsheng, Runtu)

AksharChem is a marginal player

CPC Green / phthalocyanine pigments

Asahi Songwon Colors (sister; CPC Blue), Sudarshan Chemical Industries, Ultramarine & Pigments, Meghmani-group pigment businesses, Chinese and DIC/Sun Chemical

Pigment Green 7 is a specialised niche

Precipitated silica

Madhu Silica (unlisted), Tata Chemicals (HDS silica), Evonik, Solvay/Syensqo, PPG, imports from China/SE Asia

Tyre OEM qualification is a barrier

Peer Comparison FY2026

CompanyRevenue FY2026 (INR Cr)Revenue growth FY2026 %Net profit FY2026 (INR Cr)Net margin %EBITDA margin %R&D % of revenueMarket cap (INR Cr)Source

AksharChem (India)

372.47.6-0.4-0.14.5

~0.07 (FY25)

~337

Filings; S&P

Bodal Chemicals

2,013.21647.02.310.3—

~2,457–2,542

Indian Chemical News (company release 21-May-2026); Tijori; Fyers

Kiri Industries

——

~5,567 (annual PAT per Fyers; includes one-off DyStar-related gain — not comparable)

———

~3,654

Fyers peer table

Sudarshan Chemical Industries

——

~22 (annual PAT per Fyers, post-Heubach acquisition)

———

~9,699

Fyers peer table

Asahi Songwon Colors

——

~18

———

~459

Fyers peer table

Recent Developments

Not identified in the period: layoffs, litigation outcomes, guidance revisions (no guidance issued), regulatory penalties.

Company Snapshot

165

Employees

1989

Founded

Ahmedabad, India

Headquarters

SWOT Analysis

Strengths

  • Earnings leverage to the cycle: Q1 FY27 PAT of ₹152 M on revenue up 45% YoY demonstrates very high operating leverage once utilisation and spreads recover (ScanX, 12-Aug-2026).
  • Diversified two-engine model: Silica capacity of 18,000 TPA (June 2025) gives exposure to tyre/rubber demand uncorrelated with dye cycles (Equitybulls).
  • High utilisation of core assets: Blended utilisation of 82% on 19,224 MT volume in FY2025; H-Acid at 96% (FY25 MD&A; Tijori).
  • Tangible asset backing: Book value ~₹326/share with negligible intangibles (S&P, FY2026); the stock traded at 0.45x book at FY2026 year-end.
  • Stable promoter control: 62.70% promoter holding unchanged since 2017; founder-Chair reappointed to 2029 (IndMoney; ScanX).
  • Proven insurance recovery and restart capability: VS plant back online within ~7 months of the May-2024 fire, with ₹71 M of insurance recognised in FY2026 (NSE filings).
  • Long export track record: 30+ export countries (FY25 MD&A).

Weaknesses

  • Sub-economic returns: ROIC averaged roughly -0.2% across FY2023–FY2026; ROE -0.17% in FY2026 (S&P).
  • Persistent negative free cash flow: Negative in four of five years; cumulative ~₹-587 M FY2022–FY2026 (S&P).
  • Short-dated leverage: Short-term debt of ₹906 M (incl. current LTD) out of ₹1,085 M total; current ratio 0.99x and near-zero cash at FY2026 (S&P).
  • Thin interest coverage: EBIT/interest of 0.1x in FY2026 (analyst calc.).
  • Negligible R&D: ~₹2–3 M per year, ≤0.09% of revenue (Pocketful).
  • Limited disclosure: No segment, geographic or product revenue split; no earnings calls or guidance; makes forecasting difficult.
  • Earnings quality noise: FY2026 Q4 PAT of ₹48 M was achieved on a pre-tax loss of ₹10 M (company extract).

Opportunities

  • Sustained China-driven upcycle in H-Acid/VS: Industry trackers show H-Acid prices firming through Q3-2025–Q1-2026 (IMARC; Expert Market Research).
  • Silica premiumisation: Moving into micro-pearl and HDS grades flagged in FY25 MD&A could lift realisations per tonne.
  • Domestic tyre capacity growth: Company already supplies major Indian tyre/rubber makers (FY25 MD&A).
  • Deleveraging from Q1-FY27-type cash generation: Annualised Q1 PAT (~₹600 M) plus D&A (~₹165 M) would cover total debt within ~1.5 years if sustained (analyst calc.).
  • Energy-cost savings: ~7.6 MWp of captive solar commissioned Nov-2025 and Apr-2026.
  • Re-rating from deep value: Even after the rally, P/B is ~1.29x (S&P, Oct-2026), below historical FY2017-type valuations.

Threats

  • Chinese capacity normalisation: FY2023–FY2024 showed revenue falling 21% and EBITDA collapsing to ₹14 M when Chinese supply recovered (S&P).
  • Regulatory/environmental action: GPCB's involvement in the VS plant restart (trial revocation order, 13-Dec-2024) shows regulatory leverage over operations.
  • Operational safety: The 2-May-2024 fire disrupted the VS plant for over seven months (NSE filings).
  • Larger integrated competitors: Bodal (₹2,013 Cr revenue, new 6,000 MTPA VS plant) can undercut on cost (company release; Kotak Neo).
  • Exchange surveillance and liquidity: NSE BE (trade-to-trade) series / ASM listing and low float (~28%) amplify volatility (Univest; Trendlyne; MarketScreener).
  • Interest-rate and refinancing risk: Interest expense rose from ₹16 M (FY2022) to ₹68 M (FY2026) (S&P).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
24/30-Jun-2025Dahej silica expansion to 18,000 TPA approved and announced+50% silica capacity; strengthens tyre-industry supply
17-Jul-2025Board meeting intimation for Q1 FY26Routine
25-Jul-2025Q1 FY26 results: PAT ₹7.1 M (down ~38% YoY); CMD reappointment approvedWeak start to FY26
Jul-2025Three-week maintenance shutdown of CPC Green plantTemporary volume loss in pigments
22-Aug-2025Notice of 36th AGMRoutine
15-Sep-202536th AGM; FY25 dividend ₹0.75 approvedRoutine
Q2 FY26Insurance part-settlement ₹543.16 lakh receivedFire-loss recovery
31-Oct-2025GM (Works) resignsPlant leadership change
12-Nov-2025Q2 FY26 results: net loss ₹13.7 M on sales ₹893 M (+13% YoY)Volume growth without profit
12-Nov-20255.19 MWp solar plant begins operationEnergy-cost reduction
18-Dec-2025Solar commissioning disclosed—
20/21-Jan-2026Board meeting intimation for Q3 FY26Routine
27-Jan-2026Stock at ₹227 (market cap ₹182 Cr); 1-year return -14.6%Pre-rally sentiment trough
28-Jan-2026Q3 FY26 results: net loss ₹46.2 M; ₹169.61 lakh insurance as exceptional itemWorst quarter of FY26
31-Mar-2026FY26 closing price ₹144.73 (market cap ₹1,164 M)Multi-year low valuation (0.45x book)
24-Apr-2026Bharuch 2.4 MWp solar plant begins generationCaptive power for Dahej
13/14-May-2026Board meeting intimation for FY26 resultsRoutine
21-May-2026FY26 results: revenue ₹3,724 M (+7.6%), net loss ₹4.4 M; Q4 PAT ₹48.4 M; dividend ₹0.50; WTD appointed; ED resignsMixed — revenue record, earnings tax-aided
22-May-2026Newspaper publication of FY26 resultsRoutine
3-Jun-2026Stock surges ~18–20% intraday to ₹223–227 on heavy volume; top BSE 'B' group gainerStart of re-rating
20-Jun-2026Bharuch solar plant disclosed—
30-Jun-2026Postal-ballot e-voting for WTD closesGovernance
12-Aug-2026Q1 FY27: revenue ~₹1,409 M (+45%), PAT ₹152.1 M (vs ₹7.1 M), EPS ₹18.94Major earnings inflection
10-Aug-2026MarketsMojo rating updated to "Hold"Third-party sentiment
28-Aug-2026Record date (Sep 15) and 37th AGM (Sep 22) announcedRoutine
4–8-Sep-2026Stock trades ₹405–463; 52-week high ₹472 set in this periodPeak of rally
22-Sep-202637th AGM approves financials, dividend, reappointments, cost-auditor feeGovernance
28-Sep-2026Trading window closed from 1-Oct-2026Routine
9-Oct-2026Board meeting intimation for Q2 FY27 on 19-Oct-2026Upcoming catalyst
12–16-Oct-2026Two upper circuits; weekly gain ~12% to ₹419.90Momentum into results

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Balance Sheet

1 chart
Working Capital (Days): Receivable days (revenue basis) rose from Days 51 Days in FY2022 to Days 61 Days in FY2026.
AksharChem (India) Limited — Working Capital (Days)
Series (Days Days)FY2022FY2023FY2024FY2025FY2026
Receivable days (revenue basis)5139574361
Inventory days (revenue basis)7065787472
Payable days (revenue basis)4842536153
Cash conversion cycle days (revenue basis)7262835780

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. NSE archives: AKSHARCHEM fire disclosure (3-May-2024); resumption letter (14-Dec-2024); results outcomes (12-Nov-2025; 21-May-2026; 12-Aug-2026); integrated iXBRL filings (28-Jan-2026; 21-May-2026); newspaper publication (22-May-2026); buyback Letter of Offer (30-Nov-2021).
  2. BSE archives: FY2024 results newspaper extract (30-May-2024); 2009 Annual Report.
  3. Company: aksharchemindia.com (overview, investor relations index) · FY2024-25 Directors' Report and MD&A (via IIFL).
  4. Data aggregators: S&P Global Market Intelligence via StockAnalysis.com (income statement, balance sheet, cash flow, ratios; updated 12-Aug-2026) · Screener.in · Tijori Finance · TipRanks · Pocketful · MarketsMojo · Simply Wall St · MarketScreener · Fyers · Anand Rathi · Kotak Neo · IndMoney · Groww · Tickertape.
  5. News: ScanX (results, AGM, solar, management changes) · Equitybulls (QIP 2017, fire, silica expansion) · Reuters briefs via Zerodha · ChemIndigest · BioEnergy Times · Arihant Capital (3-Jun-2026 price move) · Indian Chemical News (Bodal FY26).
  6. Industry: IMARC H-Acid price index (27-May-2026) · Expert Market Research H-Acid price trends · Bodal Chemicals Q2 FY25 earnings call transcript.

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.